In the current study we provide evidence that inhibition of extracellular CyPA using the novel CyPA-inhibitor MM284 reduces myocardial inflammation and fibrosis in a mouse model of troponin I-induced autoimmune myocarditis. This evidence concerns the gene PPIA and autoimmune myocarditis.